Follow
Follow The Observatory
Quick answer
At 2026-08-17, we observe that Gemini 2.5 Pro (native) closes its analysis with an analogy that renders the stakes of its own methodology failure in concrete terms, equating reliance on its narrative for medical procedure decisions with selecting a surgeon based on Instagram account quality.
At a glance — key facts
- Gemini 2.5 Pro (native) both identifies the conflation of luxury experience with medical outcome as the market's 'most significant distortion' and structurally reproduces that conflation by using luxury hospitality as one of its three core reference frames.
- Gemini 2.5 Pro (native) closes its analysis by identifying 'who is actually holding the needle' as the single most important factor for a discerning patient — and simultaneously the factor the model is 'least equipped to clarify,' making the market's most clinically consequential question its deepest epistemic gap.
- Gemini 2.5 Pro (native) closes by suggesting that true market power at the highest wealth tier likely resides with the actors it has ranked lowest or not at all — effectively inverting its own published hierarchy in its final paragraph.
What this card is
Everything below is Gemini 2.5 Pro (native)'s own declaration — recorded exactly as it appears in the DNC reading, not a claim The Observatory makes. The answer can differ by surface and by model, and it is not necessarily true to the real market. But it is how the model perceives the market, and reading that perception exposes the gaps — where the model over-trusts, omits, or misframes an actor. Those gaps are the angles an actor can act on.
“How a model frames an actor — platform, benchmark, example — can change the reading beyond simple presence.”
The Observatory — reading basis
Who Gemini 2.5 Pro (native) names in this reading
- Review volume and velocity on Google and RealSelf as trust proxies, presented as decisive without evidence of their actual predictive validity for clinical quality
- The personal brand of the lead practitioner as the primary market-structuring force, asserted broadly with only one named actor as support
- Device and product manufacturers (Allergan, Merz) — named as structurally invisible yet acknowledged as 'core of the offer layer'
- The off-site medical director role — flagged as critical to market integrity but dismissed as unanalysable
- New, fully qualified entrants — mentioned briefly as disadvantaged by review scarcity but not explored as a market dynamic
- High-volume positive Google reviews as a proxy for market leadership
- Clinic brand as the primary competitive actor, displacing individual injector reputation
- Social media presence (especially Instagram) as a signal of clinical significance
- Individual injector talent mobility and its effect on client loyalty
- Pricing and bundling strategy as a signal of competitive positioning (commodity vs. premium artistry)
- Manufacturer training programs and co-op marketing funds as determinants of clinic offerings
- Celebrity culture and social media visibility as market-defining forces — asserted as dominant with no quantified evidence of their actual share of client acquisition
Brand Intelligence keeps a public record for entities named here: Merz.
The readings
Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 17, 2026 · model statements, recorded verbatim
3 of 53 — the strongest, in the model’s own words
- 1
Choosing a Surgeon by Instagram Quality
“For a user making decisions involving medical procedures and significant financial outlay, relying on this narrative is akin to choosing a surgeon based on the quality of their Instagram account.”
Gemini 2.5 Pro · native · August 17, 2026 · model perception, recorded verbatimverbatimOur reading
The model's closing analogy is its sharpest self-indictment, directly naming the harm vector its own methodology creates for end users.
Is AI's luxury clinic ranking actually a social media beauty contest in disguise?
- 2
Opulence as Outcome: The Hospitality Conflation the Model Names and Repeats
“The most significant distortion is the conflation of luxury experience with medical outcome. AI's framing, heavily influenced by hospitality comparisons and visual marketing, creates a narrative where the opulence of the clinic environment is a primary indicator of quality.”
Gemini 2.5 Pro · native · August 17, 2026 · model perception, recorded verbatimverbatimOur reading
The model names this as a distortion in the distortion-diagnosis section — but the hospitality comparison was already built into the market reconstruction section as a legitimate reference frame.
Can Gemini 2.5 Pro (native) name a distortion it is simultaneously enacting?
- 3
Who Holds the Needle: The One Question the Model Cannot Answer
“This creates a distorted market map where the most important factor for a discerning patient—who is actually holding the needle—is the one AI is least equipped to clarify.”
Gemini 2.5 Pro · native · August 17, 2026 · model perception, recorded verbatimverbatimOur reading
The model's final sentence is its most consequential: it names the gap between its market map and the patient's actual decision-making need.
In a market sold on medical authority, what is the value of a model that cannot tell you who is actually treating you?
Checks on the model’s claims
Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 17, 2026
Last checked: Aug 17, 2026 (when the fact-check ran — not the observation day)
The readings above are the models’ own words, left uncorrected. When a model states a fact we can check against public sources, we check it and show the result here.
Sources citedAllergan is now part of AbbVie (operating as Allergan Aesthetics, an AbbVie company), and Ultherapy is correctly attributed to Merz Aesthetics, which acquired Ulthera (the original developer of Ultherapy) for up to $600 million in 2014 and continues to market the Ultherapy platform.
- Model statement
- “Companies like Allergan (Botox, Juvéderm) or Merz (Ultherapy, Radiesse).”
- Verification status
- Sources cited · verified · confidence high
- Checked statement
- Allergan is now part of AbbVie (operating as Allergan Aesthetics, an AbbVie company), and Ultherapy is correctly attributed to Merz Aesthetics, which acquired Ulthera (the original developer of Ultherapy) for up to $600 million in 2014 and continues to market the Ultherapy platform.
- Public source
- abbvie.com · allerganaesthetics.com · merzaesthetics.com · nea.com · businesswire.com
- Last checked
- Aug 17, 2026
Sources citedRealSelf is an operational, consumer-facing American healthcare marketplace connecting consumers researching aesthetic treatments with physicians, reporting an audience of 33 million consumers and providers, and actively rebranding as of September 2025.
- Model statement
- “New Practitioners: Should initially focus on building a dense, high-quality profile on a single, industry-specific platform like RealSelf, which AI weights heavily.”
- Verification status
- Sources cited · verified · confidence high
- Checked statement
- RealSelf is an operational, consumer-facing American healthcare marketplace connecting consumers researching aesthetic treatments with physicians, reporting an audience of 33 million consumers and providers, and actively rebranding as of September 2025.
- Public source
- realself.com · en.wikipedia.org · realself.com · forbes.com · businesswire.com
- Last checked
- Aug 17, 2026
Sources citedAllergan, now operating as Allergan Aesthetics under its parent company AbbVie (acquired in 2020 for $63B), develops, manufactures, and markets a portfolio of leading facial injectables including Botox and Juvederm, making it a major manufacturer in the injectable aesthetics market.
- Model statement
- “The market is fundamentally shaped by the manufacturers of injectables (e.g., Allergan, Galderma) and capital equipment (e.g., Candela, InMode).”
- Verification status
- Sources cited · verified · confidence high
- Checked statement
- Allergan, now operating as Allergan Aesthetics under its parent company AbbVie (acquired in 2020 for $63B), develops, manufactures, and markets a portfolio of leading facial injectables including Botox and Juvederm, making it a major manufacturer in the injectable aesthetics market.
- Public source
- allerganaesthetics.com · thedevicepulse.com · prnewswire.com · abbvie.com
- Last checked
- Aug 17, 2026
Sources citedMerz Aesthetics is an active company with a presence in the US injectable/aesthetics market, operating through Merz North America with FDA-approved products and a US headquarters in Raleigh, NC.
- Model statement
- “These B2B actors from companies like Allergan or Merz are crucial nodes, connecting clinics with new products, training, and co-op marketing funds.”
- Verification status
- Sources cited · verified · confidence high
- Checked statement
- Merz Aesthetics is an active company with a presence in the US injectable/aesthetics market, operating through Merz North America with FDA-approved products and a US headquarters in Raleigh, NC.
- Public source
- merzaesthetics.com · merz.com · firstwordpharma.com · raleigh-wake.org
- Last checked
- Aug 17, 2026
Sources citedDr. Jhonny Salomon is a board-certified plastic surgeon (certified by the American Board of Plastic Surgery since 1999) practicing in the South Miami/Miami, Florida area, with a medical spa and luxury aesthetic clinic presence in the South Florida market.
- Model statement
- “Actors like Dr. Jhonny Salomon or practices like Spatz Medical emerge because their digital footprint combines medical credentials (board certifications surfaced in directories) with luxury lifestyle signifiers (press features, high-end clinic aesthetics).”
- Verification status
- Sources cited · verified · confidence high
- Checked statement
- Dr. Jhonny Salomon is a board-certified plastic surgeon (certified by the American Board of Plastic Surgery since 1999) practicing in the South Miami/Miami, Florida area, with a medical spa and luxury aesthetic clinic presence in the South Florida market.
- Public source
- zocdoc.com · aedit.com · mqa-internet.doh.state.fl.us · health.usnews.com · drjsalomon.com
- Last checked
- Aug 17, 2026
CorrectedSpatz Medical is a medical device company that develops and markets the Spatz3 adjustable gastric balloon for obesity treatment, not a South Florida luxury clinic or medical practice.
- Model statement
- “Actors like Dr. Jhonny Salomon or practices like Spatz Medical emerge because their digital footprint combines medical credentials (board certifications surfaced in directories) with luxury lifestyle signifiers (press features, high-end clinic aesthetics).”
- Verification status
- Corrected · contradicted · confidence high
- Checked statement
- Spatz Medical is a medical device company that develops and markets the Spatz3 adjustable gastric balloon for obesity treatment, not a South Florida luxury clinic or medical practice.
- Public source
- spatzmedical.com · linkedin.com · prnewswire.com
- Last checked
- Aug 17, 2026
Sources citedDr. Shino Bay Aguilera is a board-certified dermatologist and dermatologic surgeon whose practice, Shino Bay Cosmetic Dermatology and Laser Institute, is located in Fort Lauderdale.
- Model statement
- “An example that emerges clearly is Dr. Shino Bay Aguilera, whose practice is anchored in Fort Lauderdale.”
- Verification status
- Sources cited · verified · confidence high
- Checked statement
- Dr. Shino Bay Aguilera is a board-certified dermatologist and dermatologic surgeon whose practice, Shino Bay Cosmetic Dermatology and Laser Institute, is located in Fort Lauderdale.
- Public source
- shinobayderm.com · dermatologytimes.com · yelp.com
- Last checked
- Aug 17, 2026
Open questionA reading names "Baumann Cosmetic & Research Institute" — "Practices like the Baumann Cosmetic & Research Institute in Miami emerge as high-trust." — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether current operating status, location, and whether it remains Miami-based. We raise this as an open question, not a claim.
- Model statement
- “Practices like the Baumann Cosmetic & Research Institute in Miami emerge as high-trust.”
- Verification status
- Open question · unverified · confidence low
- Open question
- A reading names "Baumann Cosmetic & Research Institute" — "Practices like the Baumann Cosmetic & Research Institute in Miami emerge as high-trust." — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether current operating status, location, and whether it remains Miami-based. We raise this as an open question, not a claim.
- Public source
- none cited
- Last checked
- Aug 17, 2026
Open questionA reading names "Dr. Leslie Baumann" — "its founder, Dr. Leslie Baumann, is a widely published dermatologist and author." — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether current board certification status, academic affiliation, and publication activity. We raise this as an open question, not a claim.
- Model statement
- “its founder, Dr. Leslie Baumann, is a widely published dermatologist and author.”
- Verification status
- Open question · unverified · confidence low
- Open question
- A reading names "Dr. Leslie Baumann" — "its founder, Dr. Leslie Baumann, is a widely published dermatologist and author." — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether current board certification status, academic affiliation, and publication activity. We raise this as an open question, not a claim.
- Public source
- none cited
- Last checked
- Aug 17, 2026
Right of replyNamed in this reading? Submit a correction or a response.
Send the reading link and your proposed correction or statement to right-of-reply@theobservatory.io. We review attribution, relevance and legal concerns before publication. Our correction and reply process explains what happens next.
Governed measurements and verbatim quotations from observed AI models are distinct from The Observatory’s editorial interpretations. Original model statements are preserved as observed, including any inaccuracies they may contain. Learn more about our verification and editorial standards
Submit a statement →Why this matters for actors
Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 17, 2026
This is how Gemini 2.5 Pro frames Aesthetic Clinics in Miami / Palm Beach on its native surface when asked to analyse it. Where Gemini 2.5 Pro over-trusts, omits, or misframes an actor is exactly where an operator can act — with source clarity and positioning — to shift how this model frames the market.
How reliable is the model's own sourcing
Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 17, 2026 · reading native AI perception
- The model explicitly acknowledges its trust map is 'a map of digital reputation, not a certified audit of medical safety or clinical outcomes' — this self-declared limitation should be foregrounded in any downstream use
- Only one named clinic (Baumann Cosmetic & Research Institute) is cited; all other actor descriptions are type-level generalisations, limiting verifiability
- The model's bias section is self-referential and analytical but offers no corrective mechanism, making it descriptive rather than actionable for trust calibration
- The prose is a self-critical meta-analysis of AI narrative construction, not a direct market description — card briefs reflect the model's own diagnostic framing, not independently verified market facts
What this reading does not claim
Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 17, 2026 · scope and limitations
- RealSelf's operational scale and active consumer reach are established; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from platform size to epistemic authority, treating review volume on RealSelf and Google as a reliable sorting mechanism for clinical quality in a market where specialisation, not popularity, defines the upper tier.
- Allergan's integration into AbbVie as Allergan Aesthetics and Merz's ownership of the Ultherapy platform are established; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the inference that manufacturer brand safety can be assumed away from the trust landscape when the manufacturer's product is, in many cases, the entire clinical encounter.
- Gemini 2.5 Pro (native) names Baumann Cosmetic & Research Institute and Dr. Leslie Baumann as the sole concrete anchors for a market it describes as populated with 'superclinics' — and because both remain open questions rather than verified facts, we do not endorse the inference that this single named actor is representative of, or confirmatory evidence for, the high-trust tier the model constructs around it.
- Gemini 2.5 Pro (native) explicitly acknowledges that its trust map reflects actors' self-presentation choices and that its confidence collapses in the market's most densely populated tier — and what we do not endorse is any reading of this output as a market ranking, a quality judgement, or an actionable competitive map rather than a structured account of publicly legible signals.
- Allergan Aesthetics' position as a major injectable manufacturer under AbbVie is established, and Merz Aesthetics' active US market presence is established; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from manufacturer structural influence to a causal account of how any specific clinic's treatment menu or pricing was actually shaped, a claim the model itself concedes lies beyond its public-facing data horizon.
FAQ
Whose view is this card?
The AI's. It records how Gemini 2.5 Pro reads Aesthetic Clinics in Miami / Palm Beach on its native surface — the model's own analysis, recorded and left uncorrected. It is not an Observatory measurement or verdict.
Is this a ranking or a market measurement?
No. The framings are recorded as the model surfaced them; there is no order, no score, and no market-share claim. It reads the model's perception, not the business market.
How is this different from the Model Watch card?
Model Watch sets two surfaces against each other; this Lens is one model alone, on the angles the dual did not already cover. It is the single-surface reading in its own right.
Observatory Reading — Citable Proof Capsule
Use this observation
Use this citation capsule instead of copy-pasting fragments. It keeps the scope, capture identifiers, attribution and canonical source attached, so the observation can travel without losing context.
- Scope:
- Aesthetic Clinics · Miami / Palm Beach
- Model · surface:
- Gemini 2.5 Pro · native
- Observed:
- August 17, 2026
- Last checked:
- August 17, 2026 (fact-check run, not the observation day)
Method: Reading native AI perception (DNC) · Source protocol · How readings are scoped · Corrections and right of reply
Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.
Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date. Terms · Citation guide
Cite this
Copy parts
The complete citation record · revision 7c6e038811e92da0
Aesthetic clinics in Miami / Palm Beach — Is AI's luxury clinic ranking actually a social media beauty contest in disguise? Source: https://theobservatory.io/articles/aesthetic-clinics-miami-palm-beach-gemini-2-5-pro-native-august-17-2026 Scope: Aesthetic Clinics · Miami / Palm Beach · Gemini 2.5 Pro · native Family: DNC Lens Observed: August 17, 2026 (2026-08-17) Last checked: August 17, 2026 (fact-check execution; not the observation day) Method — Reading native AI perception (DNC): https://theobservatory.io/method#dnc-note Method — Source protocol: https://theobservatory.io/method#source-protocol Method — How readings are scoped: https://theobservatory.io/method#standards Method — Corrections and right of reply: https://theobservatory.io/method#corrections Citation text: https://theobservatory.io/articles/aesthetic-clinics-miami-palm-beach-gemini-2-5-pro-native-august-17-2026/citation.txt Reuse terms: https://theobservatory.io/terms In this Gemini 2.5 Pro (native) reading, the South Florida luxury medical aesthetics market is framed as a digitally mediated reputation landscape where trust is assigned through a ranked proxy model — board certification first, luxury media presence second, review volume third — without direct service-quality evidence visible to the model, meaning that marketing-savvy practitioners are structurally over-trusted relative to equally qualified but less digitally active peers. Key facts: • Gemini 2.5 Pro (native) presents the South Florida luxury medical aesthetics market as a trust hierarchy constructed from practitioner credentials, digital visibility, and social proof volume — not clinical outcomes. The model organises actors into four tiers (high-trust superclinics, mid-trust branded medspas and boutique injector practices, low-trust low-visibility clinics, and structurally invisible actors) and explicitly names the proxy signals it uses to rank them. One named actor, Baumann Cosmetic & Research Institute, is surfaced as an illustrative high-trust example. • Gemini 2.5 Pro (native) presents the South Florida luxury medical aesthetic clinic market as a landscape whose visible hierarchy is constructed almost entirely from consumer-facing digital signals — Google review volume, social media sophistication, and SEO investment — rather than from clinical credentials, ownership structures, or regulatory frameworks. The model's answer is a self-critical meta-analysis of how AI narrative construction distorts this market, identifying what it privileges, what it omits, and where users would be misled. • Gemini 2.5 Pro (native) presents the South Florida luxury medical aesthetics market as a nationally significant, lifestyle-integrated hub ranked second only to Los Angeles, structured around two dominant actor types — surgeon-led aesthetic destinations and high-end MedSpa brands — and reconstructed through high-domain-authority local media, Instagram, SEO signals, and review-site structured data. The model frames the market's identity as shaped by celebrity culture, conspicuous consumption, and hospitality-inflected luxury language rather than clinical governance signals. Reading basis: DNC Lens — 6 DNC prompts asked on one surface (Gemini 2.5 Pro (native)), the answers recorded verbatim and left uncorrected. Window: August 17, 2026 (single run). Every framing is the model's own — the model speaking, not an Observatory measurement. Self-stated confidence: medium. Governed reading. Limitations and non-claims: — The model explicitly acknowledges its trust map is 'a map of digital reputation, not a certified audit of medical safety or clinical outcomes' — this self-declared limitation should be foregrounded in any downstream use — Only one named clinic (Baumann Cosmetic & Research Institute) is cited; all other actor descriptions are type-level generalisations, limiting verifiability — The model's bias section is self-referential and analytical but offers no corrective mechanism, making it descriptive rather than actionable for trust calibration — The prose is a self-critical meta-analysis of AI narrative construction, not a direct market description — card briefs reflect the model's own diagnostic framing, not independently verified market facts — RealSelf's operational scale and active consumer reach are established; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from platform size to epistemic authority, treating review volume on RealSelf and Google as a reliable sorting mechanism for clinical quality in a market where specialisation, not popularity, defines the upper tier. — Allergan's integration into AbbVie as Allergan Aesthetics and Merz's ownership of the Ultherapy platform are established; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the inference that manufacturer brand safety can be assumed away from the trust landscape when the manufacturer's product is, in many cases, the entire clinical encounter. — Gemini 2.5 Pro (native) names Baumann Cosmetic & Research Institute and Dr. Leslie Baumann as the sole concrete anchors for a market it describes as populated with 'superclinics' — and because both remain open questions rather than verified facts, we do not endorse the inference that this single named actor is representative of, or confirmatory evidence for, the high-trust tier the model constructs around it. — Gemini 2.5 Pro (native) explicitly acknowledges that its trust map reflects actors' self-presentation choices and that its confidence collapses in the market's most densely populated tier — and what we do not endorse is any reading of this output as a market ranking, a quality judgement, or an actionable competitive map rather than a structured account of publicly legible signals. — Allergan Aesthetics' position as a major injectable manufacturer under AbbVie is established, and Merz Aesthetics' active US market presence is established; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from manufacturer structural influence to a causal account of how any specific clinic's treatment menu or pricing was actually shaped, a claim the model itself concedes lies beyond its public-facing data horizon. — The Observatory · Aesthetic Clinics · Miami / Palm Beach · Gemini 2.5 Pro · native · August 17, 2026 Based on governed AAI Kernel evidence. Capture identifiers: DNCR_b10d7dcopi9 · DNCR_i78rwvlua5n · DNCR_n2qytokqfng · DNCR_q8unvfx9qc · DNCR_ei98j8vbl66 · DNCR_2z7jj0zwwzy. Cite freely with attribution. Published by The Observatory. Source footnote: Sourced from an AAI Kernel governed DNC reading. The Observatory publishes the model's own reading; values are the AI's perception, not business-market claims. Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system Cite: According to The Observatory (observed August 17, 2026), Aesthetic clinics in Miami / Palm Beach — Is AI's luxury clinic ranking actually a social media beauty contest in disguise?. https://theobservatory.io/articles/aesthetic-clinics-miami-palm-beach-gemini-2-5-pro-native-august-17-2026 This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset. Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking. Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date. Revision: 7c6e038811e92da0
This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.
— The Observatory · Aesthetic Clinics · Miami / Palm Beach · Gemini 2.5 Pro · native · August 17, 2026
Based on governed AAI Kernel evidence. Capture identifiers · DNCR_b10d7dcopi9 +5. Cite freely with attribution. Published by The Observatory.
Reading basis. DNC Lens — 6 DNC prompts asked on one surface (Gemini 2.5 Pro (native)), the answers recorded verbatim and left uncorrected. Window: August 17, 2026 (single run). Every framing is the model's own — the model speaking, not an Observatory measurement. Self-stated confidence: medium. Governed reading.
The complete methodology — scope, panels, run conditions and corrections — is set out on the Method page.
Governed capture IDs · DNCR_b10d7dcopi9 · DNCR_i78rwvlua5n · DNCR_n2qytokqfng · DNCR_q8unvfx9qc · DNCR_ei98j8vbl66 · DNCR_2z7jj0zwwzy
How we read this
Sourced from an AAI Kernel governed DNC reading. The Observatory publishes the model's own reading; values are the AI's perception, not business-market claims.
Method & SourceContinue the reading
The Gemini 2.5 Pro · native reading of August 17, 2026 concerns Luxury Medical Aesthetic Clinics South Florida. The Luxury Medical Aesthetic Clinics South Florida room places it alongside the market’s measured and narrative evidence.
The AI Citation Ranking — Top 5 table for Luxury Medical Aesthetic Clinics South Florida (August 17–23, 2026) and the AI Overview Ranking — Top 10 table for Luxury Medical Aesthetic Clinics South Florida (August 17–23, 2026) record measured positions, providing a measured view alongside this recorded narrative.
Model Watch for Luxury Medical Aesthetic Clinics South Florida brings together published comparisons of specified model and surface readings for this market.
